Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System. | Front Immunol | 2021 | 33692801 | PubTator, text mining | PubMed |
| Between two storms, vasoactive peptides or bradykinin underlie severity of COVID-19? | Physiol Rep | 2021 | 33687143 | PubTator, text mining | PubMed |
| BDKRB2 is a novel EMT-related biomarker and predicts poor survival in glioma. | Aging (Albany NY) | 2021 | 33686021 | PubTator, text mining | PubMed |
| SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung. | Elife | 2021 | 33683204 | PubTator, text mining | PubMed |
| A unique cardiovascular presentation of pheochromocytoma. | SAGE Open Med Case Rep | 2021 | 33680468 | PubTator, text mining | PubMed |
| Rare Recurrent Variants in Noncoding Regions Impact Attention-Deficit Hyperactivity Disorder (ADHD) Gene Networks in Children of both African American and European American Ancestry. | Genes (Basel) | 2021 | 33671795 | PubTator, text mining | PubMed |
| Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19. | Viruses | 2021 | 33669276 | PubTator, text mining | PubMed |
| A Robust Bioassay of the Human Bradykinin B2 Receptor that Extends Molecular and Cellular Studies: The Isolated Umbilical Vein. | Pharmaceuticals (Basel) | 2021 | 33668382 | PubTator, text mining | PubMed |
| Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. | Arch Toxicol | 2021 | 33660061 | PubTator, text mining | PubMed |
| Blood-brain barrier dysfunction in ischemic stroke and diabetes: the underlying link, mechanisms and future possible therapeutic targets. | Anat Cell Biol | 2021 | 33658432 | PubTator, text mining | PubMed |
| Quadruple episodes of takotsubo cardiomyopathy: a case report. | Eur Heart J Case Rep | 2021 | 33644654 | PubTator, text mining | PubMed |
| To Curb the Progression of Fatal COVID-19 Course-Dream or Reality. | Curr Hypertens Rep | 2021 | 33638064 | PubTator, text mining | PubMed |
| Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection. | J Ovarian Res | 2021 | 33632295 | PubTator, text mining | PubMed |
| A double edged-sword - The Complement System during SARS-CoV-2 infection. | Life Sci | 2021 | 33609539 | PubTator, text mining | PubMed |
| Effects of bradykinin on proliferation, apoptosis, and cycle of glomerular mesangial cells via the TGF-β1/Smad signaling pathway. | Turk J Biol | 2021 | 33597818 | PubTator, text mining | PubMed |
| Mechanosignaling pathways alter muscle structure and function by post-translational modification of existing sarcomeric proteins to optimize energy usage. | J Muscle Res Cell Motil | 2021 | 33595762 | PubTator, text mining | PubMed |
| Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial. | BMJ Open | 2021 | 33593781 | PubTator, text mining | PubMed |
| Rediscovery of a forgotten disease: Hereditary Angioedema. | Balkan Med J | 2021 | 33593720 | PubTator, text mining | PubMed |
| SARS-CoV-2 pneumonia-receptor binding and lung immunopathology: a narrative review. | Crit Care | 2021 | 33557908 | PubTator, text mining | PubMed |
| Expression of Endogenous Angiotensin-Converting Enzyme 2 in Human Induced Pluripotent Stem Cell-Derived Retinal Organoids. | Int J Mol Sci | 2021 | 33525682 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=29